BEENA SYED: Open Payments
NPI 1275840480 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$706 in 38 payments from 15 companies in 2025. Trend: 2023 $1,221 · 2024 $686 · 2025 $706
Food & beverage: $706
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $223 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $82 |
| Novo Nordisk Inc | 4 | $72 |
| PFIZER INC. | 4 | $57 |
| Amgen Inc. | 3 | $47 |
| GlaxoSmithKline, LLC. | 3 | $42 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
| SANOFI-AVENTIS U.S. LLC | 1 | $22 |
| ABBVIE INC. | 1 | $22 |
| Dexcom, Inc. | 1 | $20 |
Products named: AIRSUPRA, BREZTRI, Kerendia, Ozempic, PREVNAR 20, XIFAXAN, OTEZLA, TZIELD.
Industry payments across AR — which companies pay providers there.
